Correlation Between Vivos Therapeutics and Ekso Bionics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vivos Therapeutics and Ekso Bionics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivos Therapeutics and Ekso Bionics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vivos Therapeutics and Ekso Bionics Holdings, you can compare the effects of market volatilities on Vivos Therapeutics and Ekso Bionics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivos Therapeutics with a short position of Ekso Bionics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivos Therapeutics and Ekso Bionics.

Diversification Opportunities for Vivos Therapeutics and Ekso Bionics

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Vivos and Ekso is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and Ekso Bionics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ekso Bionics Holdings and Vivos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivos Therapeutics are associated (or correlated) with Ekso Bionics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ekso Bionics Holdings has no effect on the direction of Vivos Therapeutics i.e., Vivos Therapeutics and Ekso Bionics go up and down completely randomly.

Pair Corralation between Vivos Therapeutics and Ekso Bionics

Given the investment horizon of 90 days Vivos Therapeutics is expected to generate 1.28 times less return on investment than Ekso Bionics. But when comparing it to its historical volatility, Vivos Therapeutics is 1.21 times less risky than Ekso Bionics. It trades about 0.07 of its potential returns per unit of risk. Ekso Bionics Holdings is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  61.00  in Ekso Bionics Holdings on October 25, 2024 and sell it today you would earn a total of  3.00  from holding Ekso Bionics Holdings or generate 4.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Vivos Therapeutics  vs.  Ekso Bionics Holdings

 Performance 
       Timeline  
Vivos Therapeutics 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Ekso Bionics Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ekso Bionics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Vivos Therapeutics and Ekso Bionics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vivos Therapeutics and Ekso Bionics

The main advantage of trading using opposite Vivos Therapeutics and Ekso Bionics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivos Therapeutics position performs unexpectedly, Ekso Bionics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ekso Bionics will offset losses from the drop in Ekso Bionics' long position.
The idea behind Vivos Therapeutics and Ekso Bionics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Valuation
Check real value of public entities based on technical and fundamental data
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation